Skip to main content
SpringerLink
Log in

Hepatolgie

Rifaximin zur Reduktion Zirrhose-assoziierter Komplikationen

  • journal club
  • Published:
Gastro-News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Literatur

  1. Bass NM et al. N Engl J Med 2010;362(12):1071–81

    Article  CAS  Google Scholar 

  2. Hanouneh MA et al. J Clin Gastroenterol 2012;46(8):709–15

    Article  CAS  Google Scholar 

  3. Kang SH et al. Aliment Pharmacol Ther 2017;46(9):845–55

    Article  CAS  Google Scholar 

Literatur

  • Flamm SL et al. Rifaximin has the potential to prevent complications of cirrhosis. Ther Adv Gastroenterol 2018;11:1–10

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. I. Medizinische Klinik, Universitätsmedizin Mainz, Langenbeckstraße 1, 55116, Mainz, Deutschland

    Christian Labenz

Authors
  1. Christian Labenz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christian Labenz.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Labenz, C. Rifaximin zur Reduktion Zirrhose-assoziierter Komplikationen. Gastro-News 6, 24–25 (2019). https://doi.org/10.1007/s15036-019-0563-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15036-019-0563-y

Search

Navigation